Re the Fierce Biotech (Feuerstein) article -- they spent half the article bashing CYDY's past problems and talking about the former guy and Kamempour. They also couched it in terms like "CYDY claims" to make it seem that Amarex's screwing up the clinical trials was a matter of opinion.

Anything they can do to bash the company, they do, ESPECIALLY when there is good news. It would make me feel good to think that they might be a tad worried about their short positions.